Literature DB >> 27279864

Primary adrenal schwannoma with catecholamine hypersecretion.

Jianglong Hou1, Lizhi Zhang2, Yingkun Guo3, Huizhu Chen3, Weiya Wang4.   

Abstract

Entities:  

Year:  2016        PMID: 27279864      PMCID: PMC4889703          DOI: 10.5114/aoms.2016.59942

Source DB:  PubMed          Journal:  Arch Med Sci        ISSN: 1734-1922            Impact factor:   3.318


× No keyword cloud information.
Schwannomas are benign tumors of the nerve sheath Schwann cell or nerve cell sheath, so the tumor is also called neurilemmoma. Although this tumor can involve any place where Schwann cells are present, it arises predominantly in the head and neck region or the flexor surfaces of the extremities. Schwannomas may also occur in the retroperitoneum, and they account for approximately 5% of the primary neoplasms in this area [1]. However, primary schwannomas of the adrenal gland are extremely rare. Primary adrenal schwannomas occur most often as a rare type of incidentaloma with no evidence of hormonal hypersecretion [1-8]. When adrenal neoplasia with catecholamine hypersecretion is found, pheochromocytomas/paragangliomas need be differentiated. If pheochromocytomas/paragangliomas are overlooked or improperly treated, the clinical outcomes almost invariably prove fatal [9]. However, this case is of interest in that schwannoma arising from the adrenal gland with catecholamine hypersecretion, and its clinical presence and imaging features, must be carefully evaluated and further diagnosed. A 41-year-old woman presented with 2 months history of left upper quadrant abdominal discomfort. Her past medical or surgical history was not significant. Physical examination revealed left upper quadrant and left flank tenderness on deep palpation, and no palpable masses were identified. The results of hormonal laboratory tests found that cortisol levels were elevated (adrenaline 569 ng/l, norepinephrine 483 ng/l). Serum aldosterone, electrolytes, urinary metanephrine, and vanillylmandelic acid were within the normal range. Multi-detector computed tomography (MDCT) examination detected a well-defined mass in the left adrenal gland, measuring approximately 7.7 × 6.4 × 7.1 cm. Computed tomography (CT) images showed heterogeneous density of the mass with dot-like calcification (Figure 1). The left kidney and pancreas in the vicinity were compressed. No sign of bony or visceral involvement was revealed. Local excision was performed under anesthesia. A well-demarcated tumor in the left adrenal gland was identified and entirely removed without complication. Histopathologic examination confirmed that the tumor exhibited Antoni A areas composed of well-defined fascicles of spindle cells and loosely organized Antoni B areas. Immunohistochemical staining demonstrated that the tumor was positive for S-100 protein (Figure 2). Based on these findings, the final diagnosis was benign adrenal schwannoma. Her catecholamine level normalized immediately after the operation. Nineteen months after the excision, no recurrence or metastases have been reported.
Figure 1

Unenhanced (A) and contrast-enhanced CT (B) scan shows a well-defined soft tissue mass arising from the left adrenal gland, and dot-like calcifications in the mass are revealed

Figure 2

Microscopic examination shows the tumor exhibit Antoni A areas composed of well-defined fascicles of spindle cells and Antoni B areas (original magnification, 120; hematoxylin and eosin stain) (A). Immunohistologically, the tumor cells are positive for S-100 protein (immunohistochemical staining, 100) (B)

Unenhanced (A) and contrast-enhanced CT (B) scan shows a well-defined soft tissue mass arising from the left adrenal gland, and dot-like calcifications in the mass are revealed Microscopic examination shows the tumor exhibit Antoni A areas composed of well-defined fascicles of spindle cells and Antoni B areas (original magnification, 120; hematoxylin and eosin stain) (A). Immunohistologically, the tumor cells are positive for S-100 protein (immunohistochemical staining, 100) (B) Schwannoma is a neural sheath tumor arising from the Schwann cell or nerve-cell sheath. Although the tumor can involve any place where Schwann cells are present, involvement of the adrenals is uncommon [1-4]. Histologically, most adrenal neoplasms arise from constituent cortical cells, but adrenal schwannomas are thought to originate from nerves in the adrenal medulla. The hypothesis is supported because the adrenal medulla is innerved by two groups of myelinated nerve fibers: one is derived from the sympathetic trunk or vagus nerve; another is from the phrenic nerve. The tumors are usually benign and slow-growing, but rarely may be malignant. Most malignant neurilemmomas are associated with von Recklinghausen's disease (VRD) or other types of neurofibromatosis [2, 3]. Clinically, adrenal schwannoma is usually asymptomatic, but some patients can present with either abdominal or flank pain. Laboratory studies are typically unremarkable. When adrenal tumors secrete catecholamines, pheochromocytomas and paragangliomas should be considered for differential diagnosis. Pheochromocytomas and paragangliomas are tumors arising from sympathetic and parasympathetic paraganglia, which can be located in the adrenal medulla or in extra-adrenal abdominal, intrapelvic, or thoracic locations [10, 11]. Additionally, adrenal medulla hyperplasia may produce symptoms similar to those of pheochromocytoma. Although schwannomas are usually nonsecreting tumors, those tumors may occasionally have endocrine function. So far, to the best of our knowledge, only one case of retroperitoneal schwannoma with endocrine function has been reported in the literature. Hori et al. [7] reported a 66-year-old woman with asymptomatic retroperitoneal schwannoma, but her serum noradrenalin and vanillylmandelic acid levels were increased remarkably. Our case is extremely rare owing to the adrenal schwannoma with serum adrenaline and norepinephrine overproduction confirmed by laboratory examination. Imaging plays a key role in the diagnosis and evaluation of an adrenal mass. Although some patients may present with clinical symptoms secondary to the mass effect of tumor, most of them are discovered incidentally by imaging examination [12]. On computed tomography, adrenal schwannoma usually present a homogeneous, soft-tissue density and well-defined mass with a surrounding fibrous capsule. The magnetic resonance imaging (MRI) scan demonstrates a hyperintense or isointense lesion on T1-weighted images, and hypointense mass on T2-weighted images. Cystic degeneration and calcifications were usually detected on CT/MRI images. According to the previous literature, cystic degeneration can be detected on images in three-fourths of retroperitoneal malignant schwannomas [3-5]. In our case, CT images showed heterogeneous density of the mass with dot-like calcification. After the administration of intravenous contrast medium, adrenal schwannoma may demonstrate variable homogeneous or heterogeneous enhancement. The CT scan provides useful information concerning the anatomic location, morphologic features, and relationships to surrounding structures. When large masses are found in retroperitoneal regions, two-dimensional multiplanar and three-dimensional reconstruction images provide an important method to evaluate the mass and the involvement of the vital adjacent neurovascular structures, and offer the potential to improve diagnostic confidence and accuracy so as to avoid unnecessary biopsy. When the pheochromocytomas/paragangliomas with catecholamine hypersecretion need be differentiated, 18F-DOPA PET and 123I-MIGB are sensitive and specific imaging modalities for the detection and staging of these entities in various genotypes [11]. Recently, a minimally invasive approach using laparoscopic adrenalectomy was recommended, and CT may be helpful for establishing a surgical operation plan to excise the lesion adequately [8]. The preoperative diagnosis of primary adrenal schwannoma cannot be made based on imaging alone, and the definitive diagnosis depends on histological and immunohistochemical examinations, especially tumor cells being positive to S-100 protein [2, 9]. In conclusion, the current study demonstrates, for the first time, that a case of adrenal schwannoma with catecholamine overproduction is an extremely rare retroperitoneal neoplasm. Clinical and morphologic diagnosis of primary adrenal schwannoma may be difficult. Although extremely rare, schwannoma should be considered in the differential diagnosis of primary adrenal lesions, especially in patients with catecholamine hypersecretion.
  12 in total

Review 1.  Adrenal schwannoma: a rare type of adrenal incidentaloma.

Authors:  Yaseen Mohiuddin; Mary G F Gilliland
Journal:  Arch Pathol Lab Med       Date:  2013-07       Impact factor: 5.534

2.  Experience with adrenal schwannoma in a Chinese population of six patients.

Authors:  C Xiao; B Xu; H Ye; Q Yang; L Wang; Y H Sun
Journal:  J Endocrinol Invest       Date:  2010-06-11       Impact factor: 4.256

3.  Schwannoma of the adrenal gland: report of two cases.

Authors:  Sean K Lau; Dominic V Spagnolo; Lawrence M Weiss
Journal:  Am J Surg Pathol       Date:  2006-05       Impact factor: 6.394

4.  Adrenal Schwannoma. Report of two cases.

Authors:  Vincenzo Arena; Fabio De Giorgio; Cecilia M J Drapeau; Giovanni Monego; Domenico De Mercurio; Arnaldo Capelli
Journal:  Folia Neuropathol       Date:  2004       Impact factor: 2.038

5.  Noradrenalin-secreting retroperitoneal schwannoma resected by hand-assisted laparoscopic surgery: report of a case.

Authors:  Tomohide Hori; Kentaro Yamagiwa; Shintaro Yagi; Taku Iida; Kentaro Taniguchi; Chiduru Yamamoto; Yukitsuna Eshita; Yuji Kozuka; Haruyuki Takaki; Takuma Kato; Kanako Saito; Mie Torii; Syuji Isaji; Shinji Uemoto
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

Review 6.  Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome.

Authors:  Karel Pacak; Graeme Eisenhofer; Ioannis Ilias
Journal:  Hormones (Athens)       Date:  2009 Apr-Jun       Impact factor: 2.885

7.  Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.

Authors:  H Christian Rischke; Matthias R Benz; Damian Wild; Michael Mix; Rebecca A Dumont; Dean Campbell; Jochen Seufert; Thorsten Wiech; Jochen Rössler; Wolfgang A Weber; Hartmut P H Neumann
Journal:  J Nucl Med       Date:  2012-07-26       Impact factor: 10.057

8.  Adrenal schwannoma: CT and MRI findings.

Authors:  Kazuhiro Suzuki; Atsushi Nakanishi; Yoshihisa Kurosaki; Joji Nogaki; Emi Takaba
Journal:  Radiat Med       Date:  2007-07-27

9.  Adrenal schwannoma treated with laparoscopic surgery.

Authors:  Naoyoshi Onoda; Tetsuro Ishikawa; Takahiro Toyokawa; Tsutomu Takashima; Kenichi Wakasa; Kosei Hirakawa
Journal:  JSLS       Date:  2008 Oct-Dec       Impact factor: 2.172

10.  Incidentally discovered adrenal schwannoma.

Authors:  Ruslan Korets; Robert Berkenblit; Reza Ghavamian
Journal:  JSLS       Date:  2007 Jan-Mar       Impact factor: 2.172

View more
  5 in total

1.  Primary adrenal schwannoma: a series of 31 cases emphasizing their clinicopathologic features and favorable prognosis.

Authors:  Jun Zhou; Dandan Zhang; Wencai Li; Luting Zhou; Haimin Xu; Saifang Zheng; Chaofu Wang
Journal:  Endocrine       Date:  2019-07-05       Impact factor: 3.633

Review 2.  Adrenal schwannoma: why should endocrinologists be aware of this uncommon tumour?

Authors:  Giuseppina Incampo; Luigi Di Filippo; Erika Maria Grossrubatscher; Paolo Dalino Ciaramella; Stefano Frara; Andrea Giustina; Paola Loli
Journal:  Endocrine       Date:  2022-02-12       Impact factor: 3.633

3.  Clinical features and outcomes of adrenal schwannoma: a study of 13 cases from a single centre.

Authors:  Henghai Huang; Qijian Ding; Xiaocao Lin; Delin Li; Jingjing Zeng; Weijin Fu
Journal:  Endocr Connect       Date:  2021-05-19       Impact factor: 3.335

4.  Case report: schwannoma arising from the unilateral adrenal area with bilateral hyperaldosteronism.

Authors:  Naru Babaya; Yukako Makutani; Shinsuke Noso; Yoshihisa Hiromine; Hiroyuki Ito; Yasunori Taketomo; Kazuki Ueda; Hokuto Ushijima; Yoshifumi Komoike; Yuto Yamazaki; Hironobu Sasano; Yumiko Kawabata; Hiroshi Ikegami
Journal:  BMC Endocr Disord       Date:  2017-12-06       Impact factor: 2.763

Review 5.  Adrenal Schwannoma in an Elderly Man: A Case Report and Literature Review.

Authors:  Kenji Yorita; Takushi Naroda; Masato Tamura; Satoshi Ito; Kimiko Nakatani
Journal:  Intern Med       Date:  2021-06-26       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.